Equasens Société anonyme 0R9T.L Stock
Equasens Société anonyme Price Chart
Equasens Société anonyme 0R9T.L Financial and Trading Overview
| Equasens Société anonyme stock price | 61.29 EUR |
| Previous Close | 83.6 EUR |
| Open | 83.5 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 83.5 - 83.9 EUR |
| 52 Week Range | 57.7 - 86.6 EUR |
| Volume | 109 EUR |
| Avg. Volume | 647 EUR |
| Market Cap | 12.3M EUR |
| Beta (5Y Monthly) | 1.014176 |
| PE Ratio (TTM) | 0.3251938 |
| EPS (TTM) | 2.58 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0R9T.L Valuation Measures
| Enterprise Value | 1.27B EUR |
| Trailing P/E | 0.3251938 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.060667973 |
| Price/Book (mrq) | 7.782932 |
| Enterprise Value/Revenue | 6.253 |
| Enterprise Value/EBITDA | 21.509 |
Trading Information
Equasens Société anonyme Stock Price History
| Beta (5Y Monthly) | 1.014176 |
| 52-Week Change | 12.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 86.6 EUR |
| 52 Week Low | 57.7 EUR |
| 50-Day Moving Average | 75.23 EUR |
| 200-Day Moving Average | 74.07 EUR |
0R9T.L Share Statistics
| Avg. Volume (3 month) | 647 EUR |
| Avg. Daily Volume (10-Days) | 650 EUR |
| Shares Outstanding | 14.95M |
| Float | 4.86M |
| Short Ratio | N/A |
| % Held by Insiders | 66.84% |
| % Held by Institutions | 13.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.05 |
| Trailing Annual Dividend Yield | 1.25% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 20.84% |
| Operating Margin (ttm) | 25.37% |
| Gross Margin | 33.03% |
| EBITDA Margin | 29.07% |
Management Effectiveness
| Return on Assets (ttm) | 9.92% |
| Return on Equity (ttm) | 28.59% |
Income Statement
| Revenue (ttm) | 202.74M EUR |
| Revenue Per Share (ttm) | 13.5 EUR |
| Quarterly Revenue Growth (yoy) | 10.29% |
| Gross Profit (ttm) | 65.13M EUR |
| EBITDA | 58.94M EUR |
| Net Income Avi to Common (ttm) | 42.26M EUR |
| Diluted EPS (ttm) | 2.58 |
| Quarterly Earnings Growth (yoy) | 19.00% |
Balance Sheet
| Total Cash (mrq) | 79.54M EUR |
| Total Cash Per Share (mrq) | 5.3 EUR |
| Total Debt (mrq) | 79.99M EUR |
| Total Debt/Equity (mrq) | 47.47 EUR |
| Current Ratio (mrq) | 1.218 |
| Book Value Per Share (mrq) | 10.78 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 50.8M EUR |
| Levered Free Cash Flow (ttm) | 30.98M EUR |
Profile of Equasens Société anonyme
| Country | United Kingdom |
| State | N/A |
| City | Villers-lès-Nancy |
| Address | 5 AllEe de Saint Cloud |
| ZIP | 54601 |
| Phone | 33 3 83 15 95 95 |
| Website | https://pharmagest.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 1200 |
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
Q&A For Equasens Société anonyme Stock
What is a current 0R9T.L stock price?
Equasens Société anonyme 0R9T.L stock price today per share is 61.29 EUR.
How to purchase Equasens Société anonyme stock?
You can buy 0R9T.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Equasens Société anonyme?
The stock symbol or ticker of Equasens Société anonyme is 0R9T.L.
How many shares does Equasens Société anonyme have in circulation?
The max supply of Equasens Société anonyme shares is 146.6K.
What is Equasens Société anonyme Price to Earnings Ratio (PE Ratio)?
Equasens Société anonyme PE Ratio is 0.23757721 now.
What was Equasens Société anonyme earnings per share over the trailing 12 months (TTM)?
Equasens Société anonyme EPS is 2.58 EUR over the trailing 12 months.